Author: BusinessWire

Former nanoengineer is spearheading the creation and launch of Scientist.com’s biotech-as-a-service™ platform SAN DIEGO–(BUSINESS WIRE)–#BaaS–Scientist.com, the healthcare industry’s leading marketplace…

Former nanoengineer is spearheading the creation and launch of Scientist.com’s biotech-as-a-service™ platform SAN DIEGO–(BUSINESS WIRE)–#BaaS–Scientist.com, the healthcare industry’s leading marketplace…

Former nanoengineer is spearheading the creation and launch of Scientist.com’s biotech-as-a-service™ platform SAN DIEGO–(BUSINESS WIRE)–#BaaS–Scientist.com, the healthcare industry’s leading marketplace…

Former nanoengineer is spearheading the creation and launch of Scientist.com’s biotech-as-a-service™ platform SAN DIEGO–(BUSINESS WIRE)–#BaaS–Scientist.com, the healthcare industry’s leading marketplace…

Former nanoengineer is spearheading the creation and launch of Scientist.com’s biotech-as-a-service™ platform SAN DIEGO–(BUSINESS WIRE)–#BaaS–Scientist.com, the healthcare industry’s leading marketplace…

Triastek Opens a New Chapter for Digital Formulation Development and Intelligent Pharmaceutical Manufacturing NANJING, China–(BUSINESS WIRE)–Triastek, Inc. (“Triastek”), a pharmaceutical…

CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…

Goal is to demonstrate proof of principle in targeting IL-11 receptor as a potential treatment of primary tumors and metastatic…

Triastek Opens a New Chapter for Digital Formulation Development and Intelligent Pharmaceutical Manufacturing NANJING, China–(BUSINESS WIRE)–Triastek, Inc. (“Triastek”), a pharmaceutical…

CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…